Latest News and Press Releases

MarketNewsUpdates News Commentary NEW YORK, Nov. 11, 2025 (GLOBE NEWSWIRE) -- The growing number of companies in the field of digital health that are focused on developing and introducing...

Oculis accelerates its portfolio development with Privosegtor moving into the PIONEER pivotal program in Acute Optic Neuritis (AON) and Non-arteritic Anterior Ischemic Optic Neuropathy (NAION)...

ZUG, Sviss, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Oculis hraðar þróunaráætlun sinni í kjölfar árangursríks fundar með Matvæla- og lyfjastofnun Bandaríkjanna (FDA), með PIONEER-rannsóknaráætluninni á...

ZUG, Switzerland, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Oculis accelerates its portfolio development with Privosegtor moving into the PIONEER pivotal program in Acute Optic Neuritis (AON) and...

LONDON, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Willis, a WTW business (NASDAQ: WTW), today announced the appointment of Louie Clarke as Global Head of Claims Strategy & Execution within the company’s...

New York, Nov. 06, 2025 (GLOBE NEWSWIRE) -- November 6, 2025, New York, USA: Relm, the leading insurer specializing in emerging and innovative industries like digital assets, the space economy, AI,...

Dublin, Nov. 06, 2025 (GLOBE NEWSWIRE) -- The "Sector Scenario India Insurance Broking Market 2025" report has been added to ResearchAndMarkets.com's offering. The report delivers an in-depth...

ZUG, Switzerland, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS / XICE: OCS) (“Oculis”), a global biopharmaceutical company focused on breakthrough innovations to address...

ZUG, Switzerland, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS / XICE: OCS) (“Oculis”), a global biopharmaceutical company focused on breakthrough innovations to address...

ZUG, Switzerland, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS; XICE: OCS) (“Oculis” or the “Company”), a global biopharmaceutical company focused on breakthrough innovations to...